Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Covington
UBS
Cerilliant
Queensland Health
Express Scripts
Deloitte
Healthtrust

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,676,968

« Back to Dashboard

Summary for Patent: 5,676,968
Title: Transdermal therapeutic systems with crystallization inhibitors
Abstract:A transdermal therapeutic system is described, which is characterized in that it contains a crystallization inhibitor and optionally penetration enhancer in an active ingredient-containing adhesive matrix.
Inventor(s): Lipp; Ralph (Berlin, DE), Riedl; Jutta (Berlin, DE), Tack; Johannes (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:08/433,557
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,676,968
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,676,968

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,676,968

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany41 36 057.5Oct 31, 1991
Germany42 10 711.3Mar 27, 1992

International Family Members for US Patent 5,676,968

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2895392 ➤ Try a Free Trial
Canada 2120599 ➤ Try a Free Trial
Germany 4210711 ➤ Try a Free Trial
Germany 59208918 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Healthtrust
Mallinckrodt
Dow
Medtronic
Cipla
Colorcon
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.